Michael Lyman, in Blanding, UT - Psychologist

Michael Lyman, is a Psychologist based in Blanding, Utah. Michael Lyman is licensed to practice in * (Not Available) (license number ) and his current practice location is 356 S Main St, Blanding, Utah. He can be reached at his office (for appointments etc.) via phone at (435) 678-2992.

NPI number for Michael Lyman is 1811306723 and his current mailing address is 356 S Main St, Blanding, Utah. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1811306723.

Contact Information

	Michael Lyman,
	356 S Main St, Blanding, UT 84511-3830
	(435) 678-2992
	(435) 678-3116

Healthcare Provider's Profile

Full Name	Michael Lyman
Gender	Male
Speciality	Psychologist
Location	356 S Main St, Blanding, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1811306723
Provider Enumeration Date: 08/05/2014
Last Update Date: 08/05/2014

Medical Identifiers

Medical identifiers for Michael Lyman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1811306723	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael Lyman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michael Lyman, 356 S Main St, Blanding, UT 84511-3830 Ph: (435) 678-2992	Michael Lyman, 356 S Main St, Blanding, UT 84511-3830 Ph: (435) 678-2992

News Archive

Adults with spinal cord injury are at higher risk of developing mental health disorders

In a new study, published in Mayo Clinic Proceedings, researchers from Michigan Medicine find adults with spinal cord injury are at a higher risk of developing mental health disorders, including depression and anxiety, compared to adults without the condition.

PerkinElmer, LinaTech enter oncology technology development and marketing agreement

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has entered into a joint technology development and marketing agreement with LinaTech, a leading manufacturer of medical devices and software for treating cancer with radiotherapy.

FDA grants OTC clearance for AliveCor Heart Monitor

AliveCor, Inc. today announced that the U.S. Food and Drug Administration has granted the company over-the-counter (OTC) clearance for the AliveCor Heart Monitor, a single-channel ECG (electrocardiogram) recorder, previously available by prescription only. The device is available now for pre-order purchase with shipments beginning in March.

Researchers find method to expand blood stem cells used to treat cancer patients

A team of scientists from the University of Colorado School of Medicine has reported the breakthrough discovery of a process to expand production of stem cells used to treat cancer patients.

ACT files IND application to initiate Phase I/II study for Dry AMD

Advanced Cell Technology, Inc. announced today that it has filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using human embryonic stem cell (hESC) derived retinal pigment epithelial (RPE) cells to treat patients with Dry Age-Related Macular Degeneration (Dry AMD).

Michael Lyman, - Psychologist in Blanding, UT